Acurx Pharmaceuticals Inc.
ACXP | NASDAQ
$1.33
-$0.06 (-4.32%)
At close: Sep 21, 2026, 4:00 PM ET
$1.31
-$0.02 (-1.50%)
After-hours:
Sep 21, 2026, 7:30 PM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -0.47 | -0.93 | -3.33 | -3.56 | -3.46 | -17 |
PEG Ratio | 0.01 | 0.04 | -1.15 | 0.34 | -0.02 | 0.75 |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 0.71 | 22.54 | 10.40 | 5.88 | 3.56 | 28.96 |
P/FCF Ratio | -0.55 | -1.34 | -4.95 | -5.71 | -8.81 | -23.34 |
P/OCF Ratio | -0.55 | -1.34 | -4.95 | -5.71 | -8.81 | -23.34 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | n/a | n/a | n/a | n/a | n/a | 0.02 |
Quick Ratio | 3.18 | 1.19 | 2.53 | 4.55 | 15.71 | 6.82 |
Current Ratio | 3.18 | 1.19 | 2.53 | 4.55 | 15.71 | 6.82 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | n/a | n/a | n/a | n/a | n/a |
Return on Equity | -151.21% | -2.29K% | -312.38% | -165.31% | -102.72% | -170.27% |
Return on Assets | -103.60% | -365.56% | -189.10% | -128.97% | -96.18% | -142.68% |
Return on Invested Capital | -153.59% | -2.29K% | -312.38% | -165.31% | -103.25% | -166.18% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove ACXP